Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Five Signs a Loved One is Abusing Painkillers

Catasys Health - Tuesday, May 01, 2012

By HeathPop Staff
Abusing painkillers is a big problem in the U.S. - about 12 million people said they used painkillers for non-medical reasons in the past year, according to recent CDC estimates.

A new study found rates of newborns born addicted to opiate drugs tripled over the past decade, driven by legal and illegal use of opioids like hydrocodone and oxycodone, CBS News reported. The number of newborns with withdrawal symptoms increased from a little more than 1 per 1,000 babies in 2000 to more than 3 per 1,000 in 2009, according to the study.
 » More



Opioids Are Rarely the Answer

Catasys Health - Wednesday, February 15, 2012

Doctors need access to education and training programs that are free of industry bias.

By Andrew Kolodny; President of Physicians for Responsible Opioid Prescribing and chairman of the department of psychiatry at Maimonides Medical Center in New York City

Doctors have contributed to an epidemic of overdose deaths and addiction by overprescribing opioids. We didn’t do this out of malicious intent. For most of us, it was a desire to treat pain more compassionately that led to overprescribing. To bring this public health crisis under control, doctors must prescribe more cautiously.

In response to an industry-funded campaign, sales for opioids increased exponentially. Doctors were taught that unrealistic fear of addiction was resulting in needless suffering and that opioids would provide long-term relief of chronic pain. Doctors were misinformed.
 » More



The New Panic Over Prescription Painkillers

Catasys Health - Wednesday, February 08, 2012

By Radley Balko; Senior Writer and Investigative Reporter, The Huffington Post
"I don't want to be doped up all the time," says Mary Maston. "I want to be able to function. I have to be able to function for my kids. But the pain prevents me from doing so."

In 2008, Maston, 37, was diagnosed with Medullary Sponge Kidney, a congenital disorder that causes her to form large, painful kidney stones. She has since had three lithotripsy surgeries, all of which she says were unsuccessful, and has had to be hospitalized to drain the blood from her kidneys. She has also been diagnosed with stage two Chronic Kidney Disease.


For the first few years after her diagnosis, Maston lived in Tennessee. There, she says, "my doctor was pretty good about writing me a prescription for pain medication when I needed one." But in March 2011, Maston and her family moved to Florida to be closer to her husband's family, and her condition worsened. Florida doctors, she says, were much less willing to prescribe the level of medication she needed. In September, the daily pain from her condition forced her to quit her job. She says she's been to the emergency room seven times in the last eighth months, all due to overwhelming pain.
 » More



As painkiller addiction rises, stronger brand hits market

Catasys Health - Thursday, February 02, 2012

By Amy Bell
Two years ago, 28 percent of patients admitted to the Dawn Farm rehabilitation center in Ann Arbor had opiate addictions. Last year, that number rose to 55 percent, said Jim Balmer, president of the organization.

"Opiates overall are dramatically on the rise," he said.


Though the numbers are increasing at an alarming rate, painkillers are still in demand and drug manufacturers are cashing in.


Zogenix, a San Diego-based pharmaceutical company, has plans to apply early this year for U.S. Federal Drug Administration approval of its product, Zohydro. Zogenix is one of four companies that have started testing the pain reliever product. If approved, Zohydro could be on the market beginning in 2013.
 » More



Mood Disorders Up Risk of Opioid Abuse

Catasys Health - Wednesday, December 14, 2011

By Rick Nauert, PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D.

Mood Disorders Up Risk of Opioid AbuseResearchers have discovered that people suffering from mood and anxiety disorders are more likely to use and abuse non-prescription opioids.

The illnesses associated with abuse of opioids include bipolar disorder, panic disorder and major depression.
Mood disorders in general heighten the risk for substance abuse. In this study,  investigators made a distinction between prescription opioids commonly used for treatment of chronic and acute pain and opioid use that occurs absent a prescription. » More



Painkiller Overuse: Addicted Newborns, Oregon's High Rate of Abuse, Roots of the Epidemic, Criminals Profiting

Catasys Health - Monday, November 14, 2011

By Joe Rojas-Burke, The Oregonian
Oregon's rate of use of opiates without a prescription is the second highest in the U.S. after Oklahoma. A recent federal study suggests that Oregon doctors' greater willingness to prescribe opioid pain relievers may partly explain the state's exceptionally high rate of abuse. It found that rates of use without a prescription ranged from lows of 3.6 percent in Nebraska and Iowa, to highs of 6.8 percent in Oregon and 8.1 percent in Oklahoma. Legal sales ranged from less than 4 kilograms per 10,000 people in Illinois to more than 11 kilograms in Oregon, Tennessee, Nevada and Florida. » More





| 1 2 | Next

 

 
  Tags
 
stratified alcohol drinking drug use PTSD pain medication hospital marijuana bipolar disorder codeine behavioral health care services ADHD relapse prevention naloxone addiction treatment binge drinking care coaching morphine double-blind methamphetamine dependence physician- patient relations opioid antagonist ADD Opioid Medications Catasys recovery network over-the-counter substances depression CIWA diabetes SD members Harold Urschel predictive modeling health plan behavioral health dependence issues substance use disorder treatment post-traumatic stress disorder randomized placebo drug addicts percocet opiod abuse craving score methadone smoking drinking reduction in use communication anxiety muscle relaxant nicotine pain pills behavioral healthcare services ER Health Care Utilization medical vivitrol substance dependence health insurance hospitalizations sobriety substance dependence costs Co Occurring Disorders opioid overdose hydrocodone stimulants reducing craving drug treatment mental illness suboxone buprenorphine opioid abuse mental health opiates emergency room high-utilizing alcohol dependence drug abuse depression screening methamphetamine cocaine treatment prometa sober pain killers gabapentin data mining cocaine alcohol treatment oxycodone behavioral health care drug addiction recovery opiod-based narcotic SD health insurance alcohol OnTrak vicodin painkillers urine drug screen alcoholism sugar identification trauma addiction UnitedHealthcare withdrawal flumazenil Journal of Psychopharmacology social network addict meth fentanyl medical costs Raymond Anton psychosocial craving opioid overdose health insurance medical and behavioral costs opioid-drug interactions contract OxyContin prescriptions heroin cigarettes substance dependence chronic pain Opioid Treatment health reform reduction in craving Research Across America placebo-controlled stress behavioral healthcare facebook primary care relapse
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025